Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Nov;23(11):e480.
doi: 10.1016/S1470-2045(22)00628-3.

Appropriateness of integrating survival with quality of life and toxicity measures in a single endpoint in ovarian cancer clinical trials

Frédéric Fiteni  1
Affiliations
Comment

Appropriateness of integrating survival with quality of life and toxicity measures in a single endpoint in ovarian cancer clinical trials

Frédéric Fiteni. Lancet Oncol. 2022 Nov.

Erratum in

No abstract available

PubMed Disclaimer

Conflict of interest statement

I have received consulting fees from AstraZeneca, BMS, Clovis pharma, Daiishi-Serono, GSK, Jansen, Lilly, Novartis, Pfizer, Seagen, and Gilead, and support for attending meetings or travel from Pfizer, Lilly, and AstraZeneca.

Comment on

  • Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
    Vergote I, Gonzalez-Martin A, Lorusso D, Gourley C, Mirza MR, Kurtz JE, Okamoto A, Moore K, Kridelka F, McNeish I, Reuss A, Votan B, du Bois A, Mahner S, Ray-Coquard I, Kohn EC, Berek JS, Tan DSP, Colombo N, Zang R, Concin N, O'Donnell D, Rauh-Hain A, Herrington CS, Marth C, Poveda A, Fujiwara K, Stuart GCE, Oza AM, Bookman MA; participants of the 6th Gynecologic Cancer InterGroup (GCIG) Ovarian Cancer Consensus Conference on Clinical Research. Vergote I, et al. Lancet Oncol. 2022 Aug;23(8):e374-e384. doi: 10.1016/S1470-2045(22)00139-5. Lancet Oncol. 2022. PMID: 35901833 Free PMC article. Review.

LinkOut - more resources